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  Staphylococcus aureus is a Gram-positive bacterium that causes varieties of 
serious infections, and thus remains a significant threat to public health. The Mu50 
glycopeptide-resistant S. aureus strain has reduced susceptibility to vancomycin, a 
glycopeptide antibiotic that is heavily relied on for the treatment of infections caused by 
S.aureus. The two component system GraSR genes from Mu50 glycopeptide-resistant 
S.aureus have been identified as a mediator in a rapid signal transduction cascade that 
occurs when the bacteria cell wall is stressed by antibiotics. Mu50 S. aureus, GraS and 
GraR were successfully cloned, expressed and purified using Glutathione Sepharose 4B 
for GraS which is designed for a single step purification of GST fusion protein, while GraR 
was purified using Fast Protein Liquid Chromatography with an anion exchanger resin 
DEAE Sepharose. The proteins are now ready for subsequent kinetics studies to 
investigate their role in cell wall stress by antibiotics, and regulation in cell wall 
biosynthesis.    
The Analysis of the Native Molecular Weight of the Citrate/Methylcitrate 
Synthase mmgD from strain 168” of Bacillus subtilis, a rod shape gram-positive 
bacterium, capable of forming endospore during inadequate supply of nutrients, and 
the mother cell metabolic gene (mmg) is one operon that is expressed during this 
 
 
 
sporulation. The mmgD protein is one of the six open reading frames (ORFs) of the mmg 
operon and was shown previously to be a combined citrate/methylcitrate synthase. The 
goal of this work was to determine the native molecular weight of this protein. Gel 
filtration chromatography is one of the methods use in determining the native state of a 
protein by comparing to known standard proteins molecular weights. The previously 
cloned mmgD gene was expressed, purified and subjected to gel filtration 
chromatography to establish its apparent native molecular weight. The analysis showed 
that a major fraction of the protein existed as a monomer while a very small fraction 
eluted from this column showed an aggregation of proteins. 
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CHAPTER I 
INTRODUCTION 
 
 
I.A. Background View of Staphylococcus aureus (Mu50 strain) 
                   Staphylococcus aureus is a Gram-positive spherical bacterium that occurs in 
microscopic yellow clusters resembling grapes. It is a major human pathogen and a 
significant public health threat that causes a variety of serious and suppurative (pus 
forming) infections hence normally referred to as hospital acquired (nosocomial) 
infection of surgical wounds. This pathogen has been particularly efficient at developing 
strains that are highly resistant to antibiotics (Timothy R. & Robin A. Howe 
(2002).Strains of methicillin-resistant Staphylococcus aureus (MRSA) have been a 
problem in hospitals for many years and have recently begun spreading outside hospital 
settings and within the community. Recent studies have shown that S. aureus is capable 
of mounting a response to antibiotics that target cell wall peptidoglycan biosynthesis 
(Antoaneta B. & Golemi-Kotra (2008). Until recently, Vancomycin, which is a 
glycopeptide antibiotic that was introduced in the mid-1950s, was believed to have 
retained activity against all strains of S.aureus.  Therefore the spread of MRSA led to a 
heavily reliance on vancomycin, hence has led to an increase in the number of 
intermediate resistance strains VISA (vancomycin intermediate staphylococcus aureus). 
The first clinical strain of S. aureus resistant to vancomycin (MU50) was isolated in 1997 
from the pus of a Japanese male baby with a surgical wound infection that did
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not respond to vancomycin (Kuroda M, et al (2001). Similar strains have been reported 
from many other countries around world, irrespective of the controversy surrounding 
the definition of this type of resistance as MIC (Minimal Inhibitory Concentration), which 
varies in different countries it is used and also in the methods to detect it. There are 
some phenotypic differences between vancomycin resistant strains from different 
geographical areas; a common characteristic of these strains appears to be the 
accelerated synthesis of a grossly fortified cell wall. 
1.B.  The Resistant Mechanism of VISA/hVISA (Mu50) 
                 Evidence regarding the mechanism for vancomycin resistance derives from 
studies on clinical and laboratory isolated strains of S. aureus with various levels of 
resistance. These resistant strains share the characteristics of a thickened cell wall with 
reduced levels of peptidoglycan cross-linking, that leads to an increase in free D-ala-D-
ala side chains to which vancomycin can bind (Timothy R. & Robin A. Howe (2002)). The 
thickened peptidoglycan prevents the passage of vancomycin hence clogging it within 
the matrix. This forms a meshwork which hinders other drug molecules from reaching 
the site of cell wall biosynthesis at the plasma membrane. Using differential 
hybridization, the two component system GraSR, which is constitutively activated in 
Mu50 (VISA) and Mu3 (hVISA) but strongly depressed in vancomycin-susceptible S. 
aureus (VSSA) (Hui-min Neoh, et al (2008), were identified as glycopeptide-resistant 
genes. 
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1.C. The Two Component Systems GraSR 
              Whole genome array studies of Mu50 (VISA) have been identified, among other 
overexpressed genes, the Two Components Regulatory System (TCRS) referred to as 
GraSR. These participate in a phosphotransfer-mediated signaling pathway that require 
histidine protein kinase (HK) that is conserved in GraS, and a regulatory protein GraR. 
These two genes associated with glycopeptide resistance are known to respond to cell 
wall stress (Longzhu et al, 2009) through regulation of cell wall biosynthesis. The protein 
GraS which senses the environmental stimuli such as antibiotic drugs like vancomycin, is 
capable of undergoing autophosphorylation at a conserved histidine residue, and 
through a phosphorelay cascade, transfers the phosphoryl group to a conserved aspartic 
residue of response protein GraR, thus making it active to alter specific target gene 
transcription. GraR functions as a transcription regulator and when phosphorylated at a 
conserved asparate residue, forms the biologically active GraR- dimer species. 
            These two-component systems have been implicated in vancomycin resistance in 
Enterococcus faecium (VanSR) and bacitracin in Bacillus subtilis (LiaSR). Interestingly, 
vancomycins are bacterial cell wall synthesis inhibitors (B. Antoaneta & Golemi-Kotra, 
2007). The GraSR system plays a central role in maintaining the integrity of the cell wall 
peptidoglycan and coordinates the S. aureus response to cell wall damage, much like an 
antibiotic resistance mechanism. 
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1.D. The Research Objectives 
            The overall goal of this study is to understand how the GraSR system coordinates 
the response to stress to the cell wall and subsequently maintains the integrity of the 
cell wall peptidoglycan when damaged by antibiotics like vancomycin. This is significant 
because this regulatory pathway is similar to other antibiotic resistance mechanisms 
and understanding this mechanism would lead to better formulation of these antibiotics 
for effective results. 
The objectives of this thesis work were as follows 
1.  To clone the GraS and GraR genes from Mu50 S. aureus. 
2. To express and purify the GraS and GraR proteins. 
3. To measure autophosphorylation kinetics of GraS by 32P-ATP. 
4. To measure phosphotransformation kinetics between GraS→GraR. 
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CHAPTER II 
MATERIAL AND EXPERIMENTAL METHODS 
II.A. Gene Identification and Characterization 
Identification of the GraSR genes was done using their respective reference gene 
numbers from previously described materials. Using reference gene SA0615 from 
S.aureus strain N315 (Hui-min Neoh et al, 2008), the nucleotide sequence from coding 
region 708912→ 709952, of strain Mu50 was identified as the potential GraS homolog. 
An NCBI BLAST query using this sequence returned GraS (Mu50) as a match with 100% 
sequence identity and similarity. The protein coded by this gene consists of 346 amino 
acids. The protein characteristics were analyzed on the Expasly tools website, using 
Scanprosite software, which showed a Histidine Kinase domain profile from 127-332aa, 
and the theoretical isoelectric point and molecular weight was 6.29 and 31727.22 Da 
respectively. Finally, the structure predicted that the protein possesses two 
transmembrane domains as follows; 
 Sequence Length: 346 
Sequence 1-16 inside 
Sequence 17-34 TM helix 
Sequence35 – 43 outside 
Sequence 44 - 63 TM helix 
Sequence 64 – 346 inside 
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Figure 1: GraS sequence profile showing two transmembrane domains 
The reference gene SAV0695 (Mu50 strain) with coding region at base pair 
numbers 732494- 733168 (Neoh et al, 2008) was identified as the GraR gene. The gene 
has 675 base pairs that is coding for about 225 amino acids. Investigation with Expasly 
tool software shows no transmembrane protein, no stop codons inside the sequence 
and the theoretical isoelectric point (pI) and molecular weight (MW) were computed to 
be 5.26 and 55207.25 Da, respectively. 
II.B. Primer Design of GraS and GraR Genes 
 The GraSR primers were designed with Sigma genome/DNACalc software and 
ordered from Sigma-Aldrich. The restriction enzymes were obtained from New England 
Biolabs and their cognate nucleotide sequences were included in the calculation of the 
primers. The cystoplasmic nucleotide sequence (SA0615-GraS) coding from 77-346aa 
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was cloned with glutamate (N-end rule) as penultimate amino acid after methionine, 
below is the protein sequence. 
      EIEE IKHKDLAETP FQRHTVDYLY RQISAHKEKV VEQQLQLNMHEQTITEFVHD KTPVTAMKLLIDQE 
      KNQERKQALLYEWSR INSMLDTQLY ITRLESQRKDMYFDYVSLKR MVIDEIQLTR HISQVKGIGF 
      DVDFKVDDYVYTDTKWCRMI IRQILSNALKYSENFNIEIG TELNDQHVSL YIKDYGRGIS KKDMPRIFER  
      FTSTANRNE TTSSGMGLYLVNSVKDQLGI HLQVTSTVGK GTTVRLIFPL QNEIVERMSE VTNLSF 
 
 Including the restriction enzymes nucleotides of Bam H1 for forward primer 
[5’ggatccGAAATAGAAGAAATTAAACATAAAGAT3’] and Xho1 for reverse primer 
[5’ctcgag+TGT+TTAAAATGACAAATTTGT3’]. Three (ACA) nucleotides were added to the 
3’ end of the template nucleotide sequence after the stop TAA (5’TGACAAATT 
TGTCATTTTAA + ACA 3’) and hence appeared as TGT in the complementary strand of the 
reverse primer. This was done to increase the melting point of the reverse primer to a 
close range with the forward primer melting point; this will prevent any denaturation 
that might occur due to huge temperature difference between the primers.  
 The nucleotide sequence of GraR (SAV0695), from region 732494- 733168 
which codes for the protein sequence below, was cloned. 
      MQILLVEDDN TLFQELKKEL EQWDFNVAGI EDFGKVMDTF ESFNPEIVIL DVQLPKYDGF YWCRKMREVS 
      NVPILFLSSR DNPMDQVMSM ELGADDYMQK PFYTNVLIAK LQAIYRRVYE FTAEEKRTLT WQDAVVDLSK 
      DSIQKGDDTIFLSKTEMIIL EILITKKNQI VSRDTIITAL WDDEAFVSDN TLTVNVSRLR KKLSEISMDS 
      AIETKVGKGYMAHE 
The primer was designed with the inclusion of the restriction enzymes 
nucleotides, NdeI for the direct primer [5’ACGcatatgATGCAAATACTACTAGAAGATGAC3’] 
and Hind III for the reverse primer [5’ACGaagcttTTATTCATGAGCCATATATCC3’].  
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II.C. Gene Amplification Reaction (PCR) 
The polymerase chain reaction was conducted with the following mixture 
containing dNTP, 10x Taq buffer, genomic DNA, Taq polymerase, direct and reverse 
primers and DD H2O. The reaction was programmed to run as follows: 
         Table 1: PCR stages, temperature and time. 
 
 
 
      35x 
 
II.D. Cloning, Overexpression and Purification 
Following the successful amplifications of GraS and GraR, the amplified DNAs 
were respectively sub cloned first into pSTBlue-1 vector (Novogen) before cloning into 
their destination vectors. pSTBlue-1 vector is a multipurpose cloning vector made up 
of3851bp featuring a versatile multiple cloning region with blue/white screening, dual 
opposed T7/SP6 promoters and dual kanamycin/ampicillin resistance. This end 
conversion mix produces perfectly blunt ends. The Perfectly Blunt Ends Cloning Kit was 
used and the manufacturer’s protocol followed accordingly. Two different vectors were 
used as the destination vector for GraS and GraR genes, GraS was cloned into pGEX 4T-1 
(GE Healthcare), which is a 4.9 kb plasmid with a glutathione S transferase (GST) gene 
Stages temperature time  
Separation 95
o
C 5mins 
Melting 95
o
C 30sec 
Annealing 55
o
C – 61
o
C 1min 
 Synthesis 72
o
C 1.5min 
Extension 72
o
C 10mins 
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fusion tag which aids in the purification and detection of proteins produced in E.coil. The 
GraR was cloned into pET26b (Novogen), a 6194bp expression vector with multiple 
cloning sites, that is useful for the production of recombinant protein in E.coli strain 
BL21(DE3) cells for biochemical studies. Following cloning and overexpression of the 
genes, all the different plasmids containing the insert were sequenced by SeqWright-
DNA Technology Service.   
II.D.1. Cloning, Overexpression and Purification of GraS 
The amplified DNA from PCR was cut from the gel and purified using the QIA 
Quick Gel Extraction Kit protocol. The concentration was determined at 260 nm using 
the formula [50 µg/ml *absorbance @260 nm *dilution factor (100)], 2 µL of the DNA 
was cloned intopSTBlue-1, transformed into a single cell mixture and plated on 88 mm 
LB medium plate that has kanamycin as selecting marker, X gal and IPTG for blue and 
white screening of recombinant DNA and grown for 16 hrs @37
0
C. Plasmid cultures 
from the white colonies in the master plate were grown for 16 hrs and the plasmid was 
purified and sequenced.  
II.D.1a. Cloning GraS into pGEX 4T-1 Vector 
 On confirmation of the sequenced plasmid, the plasmids pGEX 4T-1 and 
pSTBLUE/GraS were digested with restriction enzymes Bam HI and XhoI. Since the two 
restriction enzymes react effectively in the same buffer (NEBuffer 3), the samples were 
digested by both enzymes simultaneously for 1 hr. The mixtures were prepared by 
mixing the plasmid (pGEX4T-1), Bam HI, XhoI, 10x BSA, NEBuffer 3 and ddH2O.The same 
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mixture was also prepared for plasmid pSTBlue/GraS. The digestion was confirmed by 
gel electrophoresis, the result observed under UV light, and the gene of interest and the 
digested pGEX4T-1 plasmid were sliced from the gel. The two samples were purified 
with QIA Gel Extraction and Purification Kit, according to the manufacturer’s protocol. 
The concentrations were also calculated by first determining the absorbance @260 nm, 
using the formula:  50 µL/ml *absorbance @ 260 * dilution factor (100 µL).  
The GraS gene was ligated into the pGEX 4T-1 vector, a vector with a glutathione 
S transferase (GST) gene fusion tag which aids in the purification and detection of 
proteins produced in E.coil. The ligation mixture was prepared in the ratio of 1:5 insert 
and vector, respectively, and incubated at room temperature for 30mins. The ligation 
sample was prepared by mixing Insert (SA0615), vector (pGEX4T-1), T4 Ligase, 10x T4 
Ligase buffer and DD H2O. The ligation mixture was transformed into 100 µL of 
competent cells [BL21 (DE3)], and plated on 100 µg/ml ampicillin agar plate and 
incubated @ 37
0
C for 16 hrs. 
II.D.1b. Expression of pGEX4T-1/GraS 
A liquid LB culture of 600 ml was grown to mid-log phase (OD600nm= 0.6) and 
induced with IPTG at a final concentration of 1 mM and incubated at 37
o
C with constant 
shaking at 150 rpm overnight. 
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II.D.1c. Purification of GraS-GST  
The protein was subjected to a batch purification process and protocol for the 
Glutathione Sepharose 4B affinity (GE Healthcare) resin. For first time use, the resin was 
prepared using the following procedure:                                                                                                                                                 
The bottle was shaken to mix the resin with the storage buffer, one ml of the slurry was 
transferred to 2 mL on a rack and left to settle. The solution at the top was removed 
with a pipette. The resin was equilibrated with PBS buffer (@ pH7.4) after it was washed 
for 5 mins with PBS buffer five times. The GraS/pGEX 4T-1pellet (2 g) was suspended in 
15 ml of PBS buffer atpH 7.4, sonicated to liberate the protein and then centrifuged at 
25,000Xg (13 000 rpm) for 60 mins. The supernatant containing the protein was 
transferred to a 15ml tube and the washed and equilibrated resin was added. The tube 
was placed in a rotating mixer and incubated for two hours at room temperature. After 
two hours, the tube was placed in a rack to settle. The supernatant carrying unbound 
proteins was removed from the top of the resin. PBS buffer was added to the resin and 
mixed, allowed to stand for ten minutes and then the solution was removed from the 
top of the resin. This step was repeated seven times. The GST-GraS was eluted by adding 
10 mM Reduced Glutathione (Sigma, cat# G4251-25G) and 50 mM Tris at pH 8.0. This 
was mixed and allowed to stand for ten minutes at 25
0
C. The solution was removed 
from the top; this is fraction one. The procedure was repeated likewise for seven more 
times. Each fraction was analyzed by 12.5% SDS-PAGE, and the fractions that contained 
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the most pure protein were combined. The concentration of the protein was 
determined by the Bradford assay.   
II.D.2. Cloning, Overexpression and Purification of GraR 
The amplified gene from PCR was cut from a 1% agarose gel and purified with 
the QIA Quick PCR Purification Kit. The purified gene was cloned into pSTBlue-1, 
transformed into competent E.coil (NovaBlue single cell) and plated on Agar/ kanamycin 
(50 µg/ml) plate with 35 µl of 50 mg/ml Xgal and 200 µl of 10 mM IPTG for recombinant 
screening and left to grow for 16 hrs. The plasmid was isolated from white colonies, 
purified by growing in LB culture media, and sequenced. 
II.D.2a. Cloning GraR into pET26b Vector 
On confirmation of the pSTBlue /GraR cloning from sequencing, the 
pSTBlue/GraR plasmid and the destination vector (pET26b) was digested with the 
selected restriction enzymes NdeI and HindIII. The two reactions were set up for 
simultaneous digestion since the enzymes NdeI and HindIII are 100% effective in the 
same buffer (NEBuffer 2). The reaction sample was prepared as follows, 2 µL plasmid 
DNA, 1 µL NdeI, 1 µL HindIII, 3 µL NEBuffer 2 and 12 µL DD H2O. The digestion mixture 
was left for 2 hrs and the result was investigated on 1% agarose gel electrophoresis. The 
GraR gene and the vector were cut from the gel, purified, and subsequently ligated.    
Based on the spectrophotometer calculation, the PCR product was found to be 25 ng/µL 
and the vector 32 ng/µL; 4 uL of the insert was used against 1.5 µl of the vector to make 
1: 5 ligations. The ligation mixture was incubated for 30mins at room temperature, and 
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transformed into BL21 (DE3) competent cells, plated on kanamycin/ agar plate and 
incubated at 37
0
C for 16 hrs. The cells that were observed afterwards were platted on a 
master plate. 
II.D.2b. Expression of pET26b/GraR 
        A 600 ml expression culture of LB media was induced with 1 mM IPTG incubated at 
22
o
C with constant shaking at 150 rpm overnight. The culture was centrifuged after      
16 hrs, and the pellet stored at -80
o
C prior purification. 
II.D.2c. Purification of pET26b /GraR 
                Fast protein liquid chromatography (FPLC) was used in the purification of GraR. 
The pellet was suspended in loading buffer (10 mM Tris/MgCl2 at pH 7.0), sonicated at 
30% power with 60% pulse in five cycle of one minute each. The resulting supernatant 
after centrifugation was loaded onto a DEAE Sepharose column (Tricorn 5/200 mm) that 
was equilibrated with the loading buffer. The flow rate was set at 2.5 ml/min, washing 
unbound fraction with 2 column volume buffer. The protein was eluted with 8 column 
volumes of elution buffer (500 mM Tris/5 mM MgCl2 at pH 7.0) and fractions of the 
elution were collected. The fractions of the peaks that appeared in the chromatogram 
were investigated for the presence of GraR on SDS-PAGE, and the fractions that showed 
the presence of GraR on the gel were combined and desalted by passing the protein 
through a desalting column (Hiprep
Tm
 26/10 Desalting). The desalted protein was loaded 
directly onto a Heparin sepharose column (Hiprep
Tm
 Heparin FF 16/10), an affinity 
binding and ion exchange ligand for a wide range of biomolecules, including DNA 
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binding proteins like GraR. The column was equilibrated with the loading buffer (10 mM 
Tris/5 mMMgCl2 at pH 7.0) and the protein eluted with the elution buffer (500 mM Tris/ 
5 mM MgCl2 at pH 7.0). The fraction containing pure GraR were combined, concentrated 
and stored for further characterization of the protein. 
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CHAPTER III 
RESULTS AND DISCUSSION 
III.A. Amplification, Cloning and Overexpression of GraS 
GraS (SA0615-Mu50) was successfully amplified via the polymerase chain 
reaction (PCR) (figure 2). The amplified gene lies between 0.5 - 1.0Kb, which is 
consistent with expected size of 816 kb. 
                                                                                                                                                                                                
                                                               1      2      3     4 
 
                                                                                                                                   1.0 kb 
                                                                                                                                     GraS816 kb 
                                                                                                                                       0.5 kb 
 
 
Figure 2: 1% agarose gel of PCR product of GraS.                                                                                  
From left to right: Lane 1-3: amplified GraS and lane 4: 1kb DNA ladder. 
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The amplified GraS was cut from the gel, and purified using QIA Quick Gel 
Extraction Kit. The purified gene was ligated by T4 DNA Ligase into pSTBlue-1, a 
perfectly blunt end vector, transformed into single cell mixture and plated on 
agar/kanamycin plate with the addition of Xgal and IPTG for recombinant screening. The 
plate was incubated @37
o
C for 16 hrs. 
GraS/ pSTBlue sequence result. 
seq             NNAAAANGNNNGNCANTGNATNNNNNNGCCATTTNGNNNNCNCTNTAGAATNCAGCGGCN 60 
Sa0615         ------------------------------------------------------------ 
 
 
seq             GCGAGNTCGGGCCCCCACACGTGTGGTCTAGAGCTAGCCTAGGCTCGAGAAGNNNTNGAC 120 
Sa0615          ------------------------------------------------------------ 
 
 
seq             GANTTCAGATGGNTNCGAAATAGAAGAAATTAAACATAAAGATTTAGCGGAAACGCCATT 180 
Sa0615          ----------------GAAATAGAAGAAATTAAACATAAAGATTTAGCGGAAACGCCATT 44 
                                ******************************************** 
 
seq             TCAACNTCATACAGTTGATTATTTATNTCGTCAAATCTCAGCGCACAAAGAAAAGGTTGT 240 
Sa0615          TCAACGTCATACAGTTGATTATTTATATCGTCAAATCTCAGCGCACAAAGAAAAGGTTGT 104 
                ***** ******************** ********************************* 
 
seq             TGAGCAACAGTTACAATTGAACATGCATGAACAAACCATTACAGAATTTGTGCACGACAT 300 
Sa0615          TGAGCAACAGTTACAATTGAACATGCATGAACAAACCATTACAGAATTTGTGCACGACAT 164 
                ************************************************************ 
 
seq             AAAAACACCTGTGACAGCCATGAAATTATTAATTGATCAAGAAAAAAATCAAGAAAGAAA 360 
Sa0615          AAAAACACCTGTGACAGCCATGAAATTATTAATTGATCAAGAAAAAAATCAAGAAAGAAA 224 
                ************************************************************ 
 
seq             ACAGGCATTACTATATGAATGGTCTCGTATAAACTCGATGCTGGATACACAGCTGTATAT 420 
Sa0615          ACAGGCATTACTATATGAATGGTCTCGTATAAACTCGATGCTGGATACACAGCTGTATAT 284 
                ************************************************************ 
 
seq             TACTAGATTAGAATCTCAACGCAAAGATATGTATTTTGATTACGTGTCACTTAAACGCAT 480 
Sa0615          TACTAGATTAGAATCTCAACGCAAAGATATGTATTTTGATTACGTGTCACTTAAACGCAT 344 
                ************************************************************ 
 
seq             GGTCATTGATGAAATACAATTAACAAGACATATTAGTCAGGTTAAAGGTATTGGTTTTGA 540 
Sa0615          GGTCATTGATGAAATACAATTAACAAGACATATTAGTCAGGTTAAAGGTATTGGTTTTGA 404 
                ************************************************************ 
 
seq             TGTTGACTTTAAAGTGGATGATTATGTTTATACAGATACAAAATGGTGTCGTATGATTAT 600 
Sa0615          TGTTGACTTTAAAGTGGATGATTATGTTTATACAGATACAAAATGGTGTCGTATGATTAT 464 
                ************************************************************ 
 
seq             TAGACAGATTTTGTCAAACGCATTGAAATATAGTGAGAATTTTAATATTGAAATTGGGAC 660 
Sa0615          TAGACAGATTTTGTCAAACGCATTGAAATATAGTGAGAATTTTAATATTGAAATTGGGAC 524 
 
seq             AGAATTAAATGATCAACATGTTTCGTTATATATTAAAGACTATGGCAGAGGTATTAGTAA 720 
Sa0615          AGAATTAAATGATCAACATGTTTCGTTATATATTAAAGACTATGGCAGAGGTATTAGTAA 584 
                ************************************************************ 
 
 
 
 
17
seq             AAAAGATATGCCGCGAATATTTGAACGAGGATTTACGTCAACGGCTAACAGAAATGAAAC 780 
Sa0615          AAAAGATATGCCGCGAATATTTGAACGAGGATTTACGTCAACGGCTAACAGAAATGAAAC 644 
                ************************************************************ 
 
seq             GACGTCTTCAGGTATGGGTCTATATTTAGTAAATAGTGTAAAGGATCAATTAGGTATTCA 840 
Sa0615          GACGTCTTCAGGTATGGGTCTATATTTAGTAAATAGTGTAAAGGATCAATTAGGTATTCA 704 
                ************************************************************ 
 
seq             CCTGCAAGTCACGTCGACTGTTGGTAAGGGGACAACTGTCAGATTGATTTTCCCATTACA 900 
Sa0615          CCTGCAAGTCACGTCGACTGTTGGTAAGGGGACAACTGTCAGATTGATTTTCCCATTACA 764 
                ************************************************************ 
 
seq             AAATGAAATTGTTGAACGCATGTCGGAAGTGACAAATTTGTCATTTTAAACACTCGAGAT 960 
Sa0615          AAATGAAATTGTTGAACGCATGTCGGAAGTGACAAATTTGTCATTTTAAACA-------- 816 
                ****************************************************         
seq             CACAAATTCTGGATCCGATACGTAACGCNTNNNCAGCNNNNNNNNNNN 1008 
Sa0615          ------------------------------------------------ 
Seq represent the cloned gene while Sa0615 is the original sequence template. 
 
 
The restriction enzymes BamHI and XhoI were used to digest the pSTBlue-1/GraS 
plasmid on 100% sequenced result confirmation. Figure 3 below depict restriction 
digestions result showing the inserted gene, cut and uncut plasmids. 
                         1    2    3    4     5     6    7     8    9 
 
                                                                                                  Uncut plasmid 
                                                                                                      Cut plasmid 
                                                                                                        0.1 kb 
                                                                                                     Insert (GraS 816 kb) 
                                                                                                     0.5 kb 
 
                                                                                                                                                                                     
Figure 3: 1% agarose gel of restriction digestion of pSTBlue/GraS.                                                                 
From Left to right, Lane1: 1Kb DNA ladder, Lane 2, 4, 6, and 8: Uncut plasmids and Lane 3, 5, 7, 
and 9: cut plasmids. 
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The GraS genes were cut from the gel and purified using the QIA Quick 
Extraction Kit and protocol according to the manufacturer used, and the concentration 
was measured on a spectrophotometer. The purified gene was ligated into the 
destination vector pGEX4T-1 that was digested with the same enzymes BamHI and XhoI. 
The ligation products were transformed into BL21 (DE3) and plated on agar/ampicillin 
plate, then incubated at 37
o
C for sixteen hours. 
GraS/pGEX4T sequence result below; 
 
Query  43   GAAATAGAAGAAATTAAACATAAAGATTTAGCGGANNNNNNNNNNNAACGTCATACAGTT  102 
            |||||||||||||||||||||||||||||||||||           |||||||||||||| 
Sbjct  1    GAAATAGAAGAAATTAAACATAAAGATTTAGCGGAAACGCCATTTCAACGTCATACAGTT  60 
 
Query  103  GATTATTTATATCGTCAAATCTCAGCGCACAAAGAAAAGGTTGTTGAGCAACAGTTACAA  162 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   GATTATTTATATCGTCAAATCTCAGCGCACAAAGAAAAGGTTGTTGAGCAACAGTTACAA  120 
 
Query  163  TTGAACATGCATGAACAAACCATTACAGAATTTGTGCACGACATAAAAACACCTGTGACA  222 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  TTGAACATGCATGAACAAACCATTACAGAATTTGTGCACGACATAAAAACACCTGTGACA  180 
 
Query  223  GCCATGAAATTATTAATTGATCAAGAAAAAAATCAAGAAAGAAAACAGGCATTACTATAT  282 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCCATGAAATTATTAATTGATCAAGAAAAAAATCAAGAAAGAAAACAGGCATTACTATAT  240 
 
Query  283  GAATGGTCTCGTATAAACTCGATGCTGGATACACAGCTGTATATTACTAGATTAGAATCT  342 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  GAATGGTCTCGTATAAACTCGATGCTGGATACACAGCTGTATATTACTAGATTAGAATCT  300 
 
Query  343  CAACGCAAAGATATGTATTTTGATTACGTGTCACTTAAACGCATGGTCATTGATGAAATA  402 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  CAACGCAAAGATATGTATTTTGATTACGTGTCACTTAAACGCATGGTCATTGATGAAATA  360 
 
Query  403  CAATTAACAAGACATATTAGTCAGGTTAAAGGTATTGGTTTTGATGTTGACTTTAAAGTG  462 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  CAATTAACAAGACATATTAGTCAGGTTAAAGGTATTGGTTTTGATGTTGACTTTAAAGTG  420 
 
Query  463  GATGATTATGTTTATACAGATACAAAATGGTGTCGTATGATTATTAGACAGATTTTGTCA  522 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GATGATTATGTTTATACAGATACAAAATGGTGTCGTATGATTATTAGACAGATTTTGTCA  480 
 
Query  523  AACGCATTGAAATATAGTGAGAATTTTAATATTGAAATTGGGACAGAATTAAATGATCAA  582 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  AACGCATTGAAATATAGTGAGAATTTTAATATTGAAATTGGGACAGAATTAAATGATCAA  540 
 
Query  583  CATGTTTCGTTATATATTAAAGACTATGGCAGAGGTATTAGTAAAAAAGATATGCCGCGA  642 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  CATGTTTCGTTATATATTAAAGACTATGGCAGAGGTATTAGTAAAAAAGATATGCCGCGA  600 
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Query  643  ATATTTGAACGAGGATTTACGTCAACGGCTAACAGAAATGAAACGACGTCTTCAGGTATG  702 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601  ATATTTGAACGAGGATTTACGTCAACGGCTAACAGAAATGAAACGACGTCTTCAGGTATG  660 
 
Query  703  GGTCTATATTTAGTAAATAGTGTAAAGGATCAATTAGGTATTCACCTGCAAGTCACGTCG  762 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  661  GGTCTATATTTAGTAAATAGTGTAAAGGATCAATTAGGTATTCACCTGCAAGTCACGTCG  720 
 
Query  763  ACTGTTGGTAAGGGGACAACTGTCAGATTGATTTTCCCATTACAAAATGAAATTGTTGAA  822 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  721  ACTGTTGGTAAGGGGACAACTGTCAGATTGATTTTCCCATTACAAAATGAAATTGTTGAA  780 
 
Query  823  CGCATGTCGGAAGTGACAAATTTGTCATTTTAA  855 
            ||||||||||||||||||||||||||||||||| 
Sbjct  781  CGCATGTCGGAAGTGACAAATTTGTCATTTTAA  813 
Query represents the cloned gene while Sbjct represent the original sequence template. 
 A seed culture was made with the harvested plasmid and after 16 hrs was used 
to inoculate an expression culture of 600 ml that was induced at mid log phase (O.D= 
0.6) with 600 µL of 1 M IPTG. The pellet of cells (2 g) containing the GST-GraS were 
subjected to a batch purification process which involves Glutathione Sepharose 4B that 
is designed for a single step purification of glutathione S- transferase (GST) fusion 
proteins produces using the pGEX series of expression vectors.  
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Below is the result of the purification showing pure GST-GraS, protein of about 57 kDa 
lying between 50– 60 kDa. 
                                                                                                                                      GraS 57KDa 
                      100kDa              1       2      3     4      5      6       7     8     9 
                      80kDa 
                      60kDa 
                    30kDa 
                    25 kDa 
                    20 kDa 
                    15 kDa 
 
 
 
                                                                                                                             
Figure 4: 12% SDS-PAGE of GST-GraS purification.                                                                                            
From left to right: Lane1 DNA ladder, Lane2-8: GST-GraS and Lane 9: crude extract. 
 
III.B. Amplification, Cloning and Overexpression of GraR 
GraR (SAVO695) was successfully amplified via the polymerase chain reaction 
(PCR). Fig 5 depicts the result of GraR amplification gene which lies between 0.5-1.0 kb 
and the result is consistent with the expected size of GraR 675 Kb. 
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                                                                 1          2          3           4 
 
 
                          3.0 kb 
                          2.0 kb 
                          1.5 kb 
                          1.0 kb 
                         675 kb GraR 
                         0.5 kb 
 
 
Figure 5: 1% agarose gel of PCR product of GraR.                                                                                            
From left to right: Lane1: 1kb DNA ladder, Lane 2-4: amplified GraR 
 
 
The amplified GraR was cut from the gel, purified using the QIA quick gel 
extraction kit. The purified gene was ligated by T4 DNA Ligase into pSTBlue-1, 
transformed into NovaBlue single cell mixture and plated on agar/kanamycin plate with 
the addition of Xgal and IPTG for recombinant screening. The plate was incubated 
@37
o
C for 16 hrs and the white colony picked afterward and used in making a seed 
culture. The plasmid was sequenced for confirmation and below is the result. 
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pSTBlue/GraR Sequence result 
 
Query  336   ATGCAAATACTACTAGTAGAAGATGACAATACTTTGTTTCAAGAATTGAAAAAAGAATTA  395 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1     ATGCAAATACTACTAGTAGAAGATGACAATACTTTGTTTCAAGAATTGAAAAAAGAATTA  60 
 
Query  396   GAACAATGGGATTTTAATGTTGCTGGTATTGAAGATTTCGGCAAAGTAATGGATACATTT  455 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61    GAACAATGGGATTTTAATGTTGCTGGTATTGAAGATTTCGGCAAAGTAATGGATACATTT  120 
 
Query  456   GAAAGTTTTAATCCTGAAATTGTTATATTGGATGTTCAATTACCTAAATATGATGGGTTT  515 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121   GAAAGTTTTAATCCTGAAATTGTTATATTGGATGTTCAATTACCTAAATATGATGGGTTT  180 
 
Query  516   TATTGGTGCAGAAAAATGAGAGAAGTTTCCAACGTACCAATATTATTTTTATCATCTCGT  575 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181   TATTGGTGCAGAAAAATGAGAGAAGTTTCCAACGTACCAATATTATTTTTATCATCTCGT  240 
 
Query  576   GATAATCCAATGGATCAAGTGATGAGTATGGAACTTGGCGCAGATGATTATATGCAAAAA  635 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241   GATAATCCAATGGATCAAGTGATGAGTATGGAACTTGGCGCAGATGATTATATGCAAAAA  300 
 
Query  636   CCTTTCTATACCAATGTATTAATTGCTAAATTACAAGCGATTTATCGTCGTGTCTATGAG  695 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301   CCTTTCTATACCAATGTATTAATTGCTAAATTACAAGCGATTTATCGTCGTGTCTATGAG  360 
 
Query  696   TTTACAGCTGAAGAAAAACGTACATTGACTTGGCAAGATGCTGTCGTTGATCTATCAAAA  755 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361   TTTACAGCTGAAGAAAAACGTACATTGACTTGGCAAGATGCTGTCGTTGATCTATCAAAA  420 
 
Query  756   GATAGTATACAAAAAGGTGACGATACGATTTTTCTATCCAAAACAGAAATGATTATATTA  815 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421   GATAGTATACAAAAAGGTGACGATACGATTTTTCTATCCAAAACAGAAATGATTATATTA  480 
 
Query  816   GAAATTCTTATTACCAAAAAAAATCAAATCGTTTCGAGAGATACAATTATCACTGCATTA  875 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481   GAAATTCTTATTACCAAAAAAAATCAAATCGTTTCGAGAGATACAATTATCACTGCATTA  540 
 
Query  876   TGGGATGATGAAGCATTTGTTAGTGATAATACGTTAACAGTAAATGTGAGTCGTTTACGA  935 
             ||||||||||||||||||||||||||||||||||||||||||||||||| |||||||||| 
Sbjct  541   TGGGATGATGAAGCATTTGTTAGTGATAATACGTTAACAGTAAATGTGAATCGTTTACGA  600 
 
Query  936   AAAAAATTATCTGAAATTAGTATGGATAGTGCAATCGAAACAAAAGTAGGAAAAGGATAT  995 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601   AAAAAATTATCTGAAATTAGTATGGATAGTGCAATCGAAACAAAAGTAGGAAAAGGATAT  660 
 
Query  996   ATGGCTCATGAATAA  1010 
             ||||||||||||||| 
Sbjct  661   ATGGCTCATGAATAA  675 
Query represents the cloned gene while Sbjct represent the original sequence template. 
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The restriction enzymes NdeI and HindIII were used to digest the pSTBlue-1/GraR 
plasmid after the sequence was confirmed. Figure 6 below shows the restriction 
digestion result, the first two bands in lane 2 and 3 are the insert (GraR) while the last 
bands of the same lanes are the cut plasmids. 
 
 
                                                  1                   2                 3 
 
                                                                                                                                       Cut plasmid 
                                                                                                                                           3.0 kb 
                                                                                                                                           1.0 kb    
                                                                                                                                       GraR 675 kb 
                                                                                                                                        0.5 kb 
Figure 6: 1% agarose gel of pSTBlue/GraR restriction digestion.                                                                   
From Left to Right, Lane1: 1Kb DNA ladder, Lane2 and 3 cut plasmids with insert (GraR). 
 
 
The GraR genes were cut from the gel and purified using the QIA Quick 
Extraction Kit and the concentration was measured on the spectrophotometer at 
260nm.The purified gene was ligated into the destination vector pET26b that has been 
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digested with the same enzymes NdeI and HindIII. The ligation products were 
transformed into BL21 (DE3) and plated on agar/kanamycin plate and incubated at 37
o
C 
for 16 hrs.  
GraR/pET26b sequence result 
Query  60   TTATTCATGAGCCATATATCCTTTTCCTACTTTTGTTTCGATTGCACTATCCATACTAAT  119 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  675  TTATTCATGAGCCATATATCCTTTTCCTACTTTTGTTTCGATTGCACTATCCATACTAAT  616 
 
Query  120  TTCAGATAATTTTTTTCGTAAACGACTCACATTTACTGTTAACGTATTATCACTAACAAA  179 
            ||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
Sbjct  615  TTCAGATAATTTTTTTCGTAAACGATTCACATTTACTGTTAACGTATTATCACTAACAAA  556 
 
Query  180  TGCTTCATCATCCCATAATGCAGTGATAATTGTATCTCTCGAAACGATTTGATTTTTTTT  239 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  555  TGCTTCATCATCCCATAATGCAGTGATAATTGTATCTCTCGAAACGATTTGATTTTTTTT  496 
 
Query  240  GGTAATAAGAATTTCTAATATAATCATTTCTGTTTTGGATAGAAAAATCGTATCGTCACC  299 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  495  GGTAATAAGAATTTCTAATATAATCATTTCTGTTTTGGATAGAAAAATCGTATCGTCACC  436 
 
Query  300  TTTTTGTATACTATCTTTTGATAGATCAACGACAGCATCTTGCCAAGTCAATGTACGTTT  359 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  435  TTTTTGTATACTATCTTTTGATAGATCAACGACAGCATCTTGCCAAGTCAATGTACGTTT  376 
 
Query  360  TTCTTCAGCTGTAAACTCATAGACACGACGATAAATCGCTTGTAATTTAGCAATTAATAC  419 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  375  TTCTTCAGCTGTAAACTCATAGACACGACGATAAATCGCTTGTAATTTAGCAATTAATAC  316 
 
Query  420  ATTGGTATAGAAAGGTTTTTGCATATAATCATCTGCGCCAAGTTCCATACTCATCACTTG  479 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  315  ATTGGTATAGAAAGGTTTTTGCATATAATCATCTGCGCCAAGTTCCATACTCATCACTTG  256 
 
Query  480  ATCCATTGGATTATCACGAGATGATAAAAATAATATTGGTACGTTGGAAACTTCTCTCAT  539 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  255  ATCCATTGGATTATCACGAGATGATAAAAATAATATTGGTACGTTGGAAACTTCTCTCAT  196 
 
Query  540  TTTTCTGCACCAATAAAACCCATCATATTTAGGTAATTGAACATCCAATATAACAATTTC  599 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  195  TTTTCTGCACCAATAAAACCCATCATATTTAGGTAATTGAACATCCAATATAACAATTTC  136 
 
Query  600  AGGATTAAAACTTTCAAATGTATCCATTACTTTGCCGAAATCTTCAATACCAGCAACATT  659 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  135  AGGATTAAAACTTTCAAATGTATCCATTACTTTGCCGAAATCTTCAATACCAGCAACATT  76 
 
Query  660  AAAATCCCATTGTTCTAATTCTTTTTTCAATTCTTGAAACAAAGTATTGTCATCTTCTAC  719 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  75   AAAATCCCATTGTTCTAATTCTTTTTTCAATTCTTGAAACAAAGTATTGTCATCTTCTAC  16 
 
Query  720  TAGTAGTATTTGCAT  734 
            ||||||||||||||| 
Sbjct  15   TAGTAGTATTTGCAT   
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A seed culture of LB media was made and after 16hrs was used to inoculate an 
expression culture of 600 ml that was induced at mid log phase (O.D600 nm= 0.6) by        
1 mM IPTG. The purification of GraR was done with fast protein liquid chromatography 
(FPLC); using 180 ml column. The supernatant from lysis of the expression pellet 
containing the crude protein was applied to a 180 ml DEAE sepharose column that was 
equilibrated with loading buffer (10 mM Tris/5 mM MgCl2 at pH 7.0). The un-bound 
protein fractions were collected as the flow rate ran at 2.5 ml/min. The protein was 
eluted with 8 column volumes of elution buffer (500 mM Tris/5 mM MgCl2 at pH 7.0) 
while collecting 5 ml fractions.  
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Figure 7 shows the chromatogram of the DEAE sepharose purification. 
 
 
                                   A 
 
                                                                                               D                                                                  
                                            B                                  C 
 
                                                                                                                                                                              
Figure 7: DEAE chromatogram of GraR purification. 
A: UV peak                                                                                                                                                       
B: Conductance                                                                                                                                                            
C: Peak containing GraR fractions 
 D: 100% linear gradient of buffer B 
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The fractions under the UV peaks in the DEAE chromatogram were collected and 
analyzed on 12% SDS-PAGE for the presence of GraR.  
The SDS-PAGE result of the DEAE fractions is show below. 
Wells no 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Fractions 
no  
152 154 159 162 165 168 Crude 
extract 
Ladder 
DNA 
76 79 84 87 114 Ladder 
DNA 
                         Gel A                               Gel B                                                                                                                                
                 1         2   3    4   5     6   7    8          9 10 11 12 13                          14                                       
 
 
 
 
 
 
 
                                                                 26kDa GraR                                                                               
Figure 8:  12% SDS-PAGE gel of fractions from DEAE sepharose chromatography of GraR.   
GraR is a protein of 26 KDa and the rest of the bands are considered impurities,  
The fractions showing the presence of GraR (fractions 79– 87 & fraction 113–
116) were desalted by passing through a desalting column, concentrated and passed 
through heparin column afterwards to further purify GraR, since GraR is a DNA binding 
protein. 
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Figure 9 below shows the chromatogram of the heparin purification. 
 
 
 
                                                                                                  C 
                                  A                                                  B 
 
 
 
Figure 9: Heparin affinity chromatogram of GraR 
A:  UV peak                                                                                                                                                                   
B: 100% linear gradient of buffer B                                                                                                                                                 
C: Conductance 
The fractions showing peaks in the chromatogram was collected and 
concentrated down to 2 ml using a 10,000 Dalton ultrafiltration tube, the filtrate 
discarded while the proteins on top of the filter was investigated for the presence of 
pure GraR on 12% SDS-PAGE gel. 
 
 
 
29
The picture below shows the result of the investigation. 
 
                                                                                                                   80KDa 
                                                                                                                      30KDa 
                                                                                                                    25KDa 
                                                                                                                     20KDa 
Figure 10: 12% SDS-PAGE of GraR (27 KDa) after heparin affinity chromatography 
III.C. Trypsin Digestion 
             The bands in the SDS-PAGE gel of GraR and GraS that are consistent with their 
expected sizes were sliced from the gel and subjected to trypsin digestion. Two 
identifications were made which are consistent with response regulator in 
[Staphylococcus aureus subsp. aureus Mu50].Tables 2 and 3 below are the results of the 
trypsin digestions and mass spectral analyses for GraR and GraS respectively. In the 
tables are peptide sequences of the digestions with their nominal masses. The peptide 
sequences were respectively identified in the protein sequence of GraR and GraS and 
the matched peptides are in bold color.  
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Table 2: Peptide Sequence of GraR Trypsin Digestion  
Start-End Mr (calc)  Sequence by MS/MS 
19 - 35      1995.9214 ELEQWDFNVAGIEDFGK 
68-80 1459.8035 EVSNVPILFLSSR 
111-116 762.4388 LQAIYR 
118-127 1270.6193 VYEFTAEEKR 
174 2794.2927 DTIITALWDDEAFVSDNTLTVNVSR 
69-81 1459.8035 EVSNVPIIFLSSR 
 
 
1 MQILLVEDDN TLFQELKKEL EQWDFNVAGI EDFGKVMDTF ESFNPEIVIL  
    51 DVQLPKYDGF YWCRKMREVS NVPILFLSSR DNPMDQVMSM ELGADDYMQK  
   101 PFYTNVLIAK LQAIYRRVYE FTAEEKRTLT WQDAVVDLSK DSIQKGDDTI  
   151 FLSKTEMIIL EILITKKNQI VSRDTIITAL WDDEAFVSDN TLTVNVSRLR  
   201 KKLSEISMDS AIETKVGKGY MAHE 
GraR protein sequence with matching peptides. 
 
 
Table 3: Peptide Sequence of GraS Trypsin Digestion 
Start- End Mr (calc) Sequence by MS/MS 
85-93 1075.5298 DLAETPFQR 
94-101 1065.4927 HTVDYLYR 
151-160 1292.6827 KQALLYEWSR 
152-160 1164.5927 QALLYEWSR 
161-173 1566.8076 INSMLDTQLYITR 
326-337 1469.8242 LIFPLQNEIVER 
 
 
1 MNNLKWVAYF LKSRMNWIFW ILFLNLLMLG ISLIDYDFPI DSLFYIVSLN  
51 LSLTMIFLIL TYFKEVKLYK HFDKDKEIEE IKHKDLAETP FQRHTVDYLY  
101 RQISAHKEKV VEQQLQLNMH EQTITEFVHD IKTPVTAMKL LIDQEKNQER  
151KQALLYEWSR INSMLDTQLY ITRLESQRKD MYFDYVSLKR MVIDEIQLTR  
201 HISQVKGIGF DVDFKVDDYV YTDTKWCRMI IRQILSNALK YSENFNIEIG  
251 TELNDQHVSL YIKDYGRGIS KKDMPRIFER GFTSTANRNE TTSSGMGLYL  
 301 VNSVKDQLGI HLQVTSTVGK GTTVRLIFPL QNEIVERMSE VTNLSF 
GraSprotein sequence with matching peptides in bold red color. 
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The matching peptide sequence from the data of the trypsin digestion confirms the 
purification of GraS and GraR. 
III.D. Phosphorylation Kinetics  
With the successful purification of pure samples of GraS and GraR, the proteins 
are to be subjected to phosphosrylation kinetics which will establish the 
autophosphorylation capability of GraS and its phosphotransfer assay to GraR. The 
autophosphorylation activity of GST-GraS in the presence of with 
32
P-ATP (3000 
Ci/mmol) is expected to be a time dependent experiment indicating a progressive 
reaction as a graph of band intensities against time. This will also show that GraS is 
capable of transducing a stress signal before S. aureus starts to duplicate (duplication 
time of S. aureus is 30 mins) (Antoaneta Belcheva & Dasantila Golemi-Kotra (2008). 
Subsequent incubation is expected to result in a rapid transfer of the phosphate from 
GST-GraS-P to GraR. It is expected that 70% of the phosphoryl group will be transferred 
in 30 seconds. This will be analyzed by 12% SDS-PAGE electrophoresis and 
autoradiography. 
III.E. Conclusion and Future Experiments 
GraS and GraR were successfully cloned and purified as was established by the 
sequencing results and the Trypsin digestion with MS. Bioinformatics suggested that the 
GraS protein has an N- terminal transmembrane domain and the C- terminal domain is 
the kinase for GraR. GraR is an expected two domain response regulatory protein that is 
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also made up of N-terminal regulatory domain and a C- terminal DNA binding domain 
referred to as the effector domain. The kinetics of the GraS autophosphorylation and its 
subsequence phosphotransfer (which is expected to happen within 30sec) is expected 
to indicate that S. aureus (Mu50) is capable of a rapid response to antibiotics that 
damage the cell wall of the bacteria. The signaling transduction process is mediated 
through these phosphorylation events. The phosphorylation kinetics of GST-GraS in the 
presence of ATP is to suggest that the autophosphorylation is time dependent and a 
progressive reaction. These queries are expected to establish that the GraSR two 
component systems is the main pathway through which rapid signal transduction is 
conducted as a response to bacterial cell wall damage and identification of these two 
proteins will lead to further experiments, designed to study their roles in cell wall 
damage repair.
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CHAPTER IV 
 INTRODUCTION OF THE mmgD PROTEIN 
               The mother cell metabolic gene operon (mmg) is expressed during sporulation 
of Bacillus subtilis, a rod shape Gram-positive bacterium (J.J. Reddick& J. Williams, 
2008). It provides a mechanism for regulating the metabolic state of the mother cell 
during development of the endospore. mmgD is one of the six open reading frames 
(ORFs) of mmg; its gene product has been shown to function as a citrate synthase 
(E.Bryan, et al, 1996) and also as a 2-methylcitrate synthase (Acharya, MS thesis. 2009). 
For better understanding of the mmgD protein, the detailed knowledge of the physical 
properties like the native molecular weight should be obtained. Gel filtration 
chromatography, also called size exclusion chromatography, is one of the common and 
widely used methods of determining apparent native protein molecular weight. The 
technique is based on the movement of proteins through a porous matrix to 
distinguished proteins of different sizes. The column of the gel filtration is made up of a 
solid stationary phase and a liquid mobile phase. The liquid mobile phase (buffer or 
solvent) which also contains the dissolved protein is allowed to flow through the solid 
phase (gel matrix) hence interacting with it, and based on their sizes, are separated. A 
mixture of protein flows through the column; the large proteins are excluded from the 
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pore and thus passed rapidly through the column between the beads with the mobile 
phase, and this volume 
is known as the void volume (Vo). While the smaller proteins and small protein 
complexes can enter the pores of the matrix, their movement is retarded and requires 
more time to elute and the volume that is eluted is called the elution volume (Ve). 
 Our goal was to measure the native molecular weight of mmgD to ascertain 
whether it exists as a monomer, dimer, trimer or tetramer etc.  
IV.A. Experimental Methods  
IV.A.1. Expression & Purification of mmgD Protein  
               A liter culture of BL21(DE3) expressing mmgD from pET28a was expressed with 
induction by IPTG, from a glycerol stock in -80
o
C and the pellet re-suspended in 20ml 1x 
binding buffer (5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl at pH 7.0, and 10% 
glycerol) and the cells sonicated and centrifuged afterwards to separate the debris. The 
supernatant was syringe filtered into a Ni-NTA column at room temperature. The 
unbound proteins were washed with wash buffer (60 mM imidazole, 500 Mm NaCl,      
20 mM Tris-HCl at pH 7.0, and 10% glycerol). While the bound proteins were eluted with 
elution buffer (200 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl at 7.9, 10% glycerol). 
The elution was collected in 1ml fractions and the fractions checked for mmgD presence 
on a 12% SDS page gel. The elution fractions that showed the presence of mmgD were 
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dialyzed (7000 MWCO) overnight in 4 liters buffer containing 25 mM Tris-HCl, 10% 
glycerol at pH 7.5. 
IV.A.2. Calibrating the Filtration Column 
             The gel filtration column used was a pre-packed column Superdex 200 10/300 GL 
(GE Healthcare) that was washed with 2 column volumes of degassed water and 
equilibrated with buffer (50 mM phosphate in 0.15 M of NaCl @ pH 7.2). Mixtures of 
purified proteins of varying known molecular masses were applied to the column. Below 
is the mixture of proteins that was used with their native molecular weight (in Da): 
Ribonuclease (13,700), carbonic anhydrase (29,000), ovalbumin (44,000), conalbumin 
(75,000), aldolase (158,000), ferritin (440,000), thyroglobulin (669,000).  Blue dextran 
2000 was used in determining the void volume. 
Table 4: Protein standards, the concentrations and the quantities used. 
Protein Molecules conc. used mg/ml Mr (Da) Amt mixed in (200.68 µl 
conalbumin (50mg) 
3  75,000  34.8 
Aldolase (50mg)  4  158,000  46.4 
Ovalbumin (50mg) 
4  44,000 46.4 
Ferritin (15mg) 
0.3  440,000  3.48 
Thyroglobulin (50mg) 
5  669,000  58 
Ribonuclease A (50mg) 
1  13,700  11.6 
Blue Dextran 2000 
1  N/A 120 
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IV.A.3. Preparation of Calibration Curve 
            To obtain the calibration curve, the partition coefficient Kav was calculated using 
the equation below:  
                      Kav = Ve - Vo 
                                Vc- Vo 
 Where Vois the void volume, Ve is the elution volume and Vc is the geometric column 
volume. A plot of Kav versus log of molecular weight will give the calibration curve. The 
calibration curve can then be use in determining the native molecular weight of the 
sample protein after the Kav of the sample protein was calculated.       
IV.B. Result 
IV.B.1. Overexpression of mmgD Protein in BL21 (DE3) 
                An expression culture was made from the already cloned pET-28a/mmgD/BL21 
(DE3) protein in glycerol stock in -80
o
C, induced with IPTG and purified by Ni-NTA 
affinity chromatography afterwards. The result of the purification was analyzed on 12% 
SDS-PAGE electrophoresis. Figure 11 shows the result of the purification. 
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            1                2              3                    4                5        6       mmgD 45KDa 
 
 
 
                                                                                                                           50KDa 
                                                                                                                          40KDa 
                                                                                                                           25KDa 
                                                                                                                            15KDa 
 
 
Figure 11: 12% SDS-PAGE Gel of mmgD Purification.                                                                                                        
From Lane 1: Crude extract, Lane2 to 5: mmgD protein and Lane 6: protein marker. 
 
 
IV.B.2.The Gel Filtration Result 
The retention time of the protein standards were determined from their 
respective peaks in the chromatogram. The chromatogram of Blue dextran used in 
determining the void volume is depicted in the figure below. 
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                                                                                      Blue dextran   7.068 ml 
 
 
 
 
 
 
Figure 12: Blue dextran chromatogram with retention time of 7.068 ml 
 
 
The standard proteins were mixed together and applied to the pre-packed size 
exclusion column that was equilibrated with buffer 50 mM phosphate in 0.15 M of NaCl 
at pH 7.2 and the flow rate adjusted to 0.5 ml/min. The diagram below shows the 
chromatogram of the gel filtration of the standard protein with the retention time. 
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                                                                                Thyroglobulin 8.5 ml 
 
                                                                                                      Adolase 12.5 ml 
                                                                                                           Conalbumin 13.5 ml 
                                                                            Ferritin                            Ovalbumin 14.5 ml 
 
 
                                                                                                                                  Ribonuclease 16.9 ml 
 
 
Figure 13: Chromatogram of the mixed protein standards with their retention time. 
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  The purified mmgD protein was applied to the column and the chromatogram is shown 
in figure 14. 
 
 
 
                                                                                                                      14.184 ml 
 
 
                                                                    7.227 ml 
                                                                                                                                          18.769 ml 
 
 
Figure 14: Chromatogram showing the retention time of mmgD protein  
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The retention time of the standard proteins were used in determining the 
partition coefficient Kav as shown in table 5. 
 
Table 5: List of protein molecules showing their partition coefficient and Log Mr.  
Protein Molecules Elution Vol (Vo) ml  Kav Mr (Da) Log Mr  
conalbumin (50mg) 
13.543  0.38  75,000  4.88  
Aldolase (50mg)  12.343  0.31  158,000  5.20  
Ovalbumin (50mg) 14.500  0.44  44,000  4.64  
Ferritin (15mg) 
10.239  0.19  440,000  5.64  
Thyroglobulin (50mg) 
8.478  0.08  669,000  5.82  
Ribonuclease A (50mg) 
16.889  0.58  13,700  4.14  
Blue Dextran 2000 7.068  
N/A N/A N/A 
mmgD 7.227  0.0094     1513561  6.18  
mmgD 
14.184  0.42  51,472  4.71  
mmgD 18.789  0.69  5,495  3.74  
 
The mmgD native molecular weight was calculated using a calibration curve of the graph 
of Kav against Log Mr for the standard proteins as shown in figure 15. Applied the 
partition coefficient Kav (y axis) mmgD proteins to the expression Y = -0.2791x + 1.735 
and solved for X = Y- 1.735/0.2791, this resulted in apparent molecular weight of 51 Da 
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for the highest peak in the chromatogram which when compare with the theoretical 
molecular weight of 45 kDa falls within monomer range.  
 
     Y axis 
 
Kav 
 
 
 
                                                                                                                        X-axis    Log Mr 
                                                                                                                                                                      
Figure 15: Calibration curve of the standard proteins. 
 
IV.C. Conclusion 
             Obtaining a detailed knowledge of physical properties of a protein such as its 
native state, molecular weight etc is very essential to a biochemist as its helps in the full 
understanding of the functions of the protein in the cells. A protein can exist in its native 
state as a monomer, dimer, trimer, or higher aggregation of proteins. An analytical tool 
like gel filtration chromatography also known as size exclusion chromatography, is a 
widely used method in determining the native molecular weight of a protein by 
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comparing the elution profile of protein of interest with the elution patterns of a 
standard protein with known molecular weight.  
mmgD was successfully grown and expressed from already cloned gene stored in -80
o
C 
(cloned by Acharya, Rejwi (2009), purified and with the successful gel filtration which 
gave an apparent molecular weight of 51,472Da which is roughly consistent with mmgD 
(theoretical molecular weight of 45 kDa) as a monomer in its native state. mmgD also 
formed apparent aggregate as the first elution peak gave unreasonable high Mr 
(molecular weight) figure of (1513561 Da).
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